KMS Medisurgi share price

BSE: 540468Healthcare Equipment & Supplies

KMS Medisurgi Limited · Face value ₹10 · Listed Apr 2017

Last traded ₹132.80 on 13 May 2026

Latest announcements

Routine notices left out.

Share price history

Daily closes since Apr 2017, adjusted for splits and bonuses

Daily close, ₹ per share

Results for the half year to Mar 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

Revenue
₹5.59 Cr−8.7% on a year ago · −15.5% on the half year before
Net profit
₹0.01 Cr−96.1% on a year ago · −93.9% on the half year before
Earnings per share
₹0.04−96.3% on a year ago
Net margin
0.3%

From revenue to net profit, ₹ crore

  1. Revenue5.6
  2. Other income0.0
  3. Finance costs0.0
  4. Profit before tax0.0
  5. Tax0.0
  6. Net profit0.0

KMS Medisurgi results by half year

Standalone: the listed company alone, without its subsidiaries. Latest half year to Mar 2026. Results for the half year to Sep 2026 are due by 14 Nov 2026, 45 days after it ends. Every company's dates are on the results calendar.

Revenue and net profit by half year, ₹ crore

  • Revenue
  • Net profit
  • Loss
7.20.6Sep 236.7−0.1Mar 247.80.1Sep 246.10.4Mar 256.60.2Sep 255.60.0Mar 26
Peak revenue ₹7.81 Cr, half year to Sep 2024; lowest ₹5.59 Cr, half year to Mar 2026A loss in 1 of the 6 half years shown

Operating and net margin by half year, per cent

  • Operating margin
  • Net margin
12.6%−2.2%12.6%2.7%7.6%8.4%−2.2%1.0%5.9%3.5%0.3%Sep 23Mar 24Sep 24Mar 25Sep 25Mar 26
₹ croreSep 2021worked outMar 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Filed 14 NovMar 2026
Revenue from operations5.504.825.685.357.156.737.816.126.625.59
––5.35–6.25–7.60–6.11–
Materials and goods bought4.383.414.243.675.255.496.304.245.083.75
Employee costs––0.53–0.49–0.57–0.53–
Other expenses––0.57–0.51–0.73–0.51–
Operating profit before depreciation––0.33–0.90–0.21–0.50–
Operating margin––5.9%–12.6%–2.7%–7.6%–
Depreciation and amortisation––0.12–0.12–0.12–0.19–
Other income0.000.050.000.010.060.030.020.010.04−0.03
Finance costs0.020.020.000.000.000.020.010.080.060.05
Profit before tax0.160.120.210.440.85−0.240.100.510.300.03
0.040.03−0.040.130.24−0.090.030.140.060.02
Tax rate24.6%24.4%−20.3%29.1%28.7%–24.6%28.6%21.9%58.7%
Net profit0.120.090.260.310.60−0.150.080.360.230.01
Net margin2.2%1.9%4.5%5.9%8.4%−2.2%1.0%5.9%3.5%0.3%
Earnings per share₹0.37₹0.28₹0.78₹0.95₹1.83−₹0.45₹0.24₹1.09–₹0.04
Earnings per share in rupees, restated for later splits and bonuses.

10 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
7.90.2Mar 177.30.1Mar 189.90.11.1Mar 19100.11.1Mar 207.50.21.0Mar 21100.21.0Mar 22110.61.0Mar 23140.50.5Mar 24140.40.9Mar 25120.20.8Mar 26
Peak revenue ₹14 Cr, year to Mar 2025; lowest ₹7.32 Cr, year to Mar 2018

Operating and net margin, per cent

  • Operating margin
  • Net margin
11.9%1.1%11.9%6.4%6.4%5.5%8.7%5.6%6.7%7.4%2.7%1.3%1.3%1.1%2.1%2.1%5.2%3.3%3.2%2.0%Mar 17Mar 19Mar 21Mar 23Mar 25Mar 26

Results for the year to Mar 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue12
  2. Materials and goods−8.8
  3. Employee costs−1.3
  4. Other expenses−1.2
  5. Operating profit0.9
  6. Depreciation−0.5
  7. Other income0.0
  8. Finance costs−0.1
  9. Profit before tax0.3
  10. Tax−0.1
  11. Net profit0.2

What the company owns

  • Plant, investments and other assets₹4 Cr
  • Receivables₹3 Cr
  • Inventory₹3 Cr
  • Cash and bank₹1 Cr

What pays for it: net worth and liabilities

  • Net worth₹8 Cr
  • Owed to suppliers₹1 Cr
  • Borrowings₹1 Cr
  • Other liabilities₹0 Cr

Profit and loss

Standalone, ₹ crore, years to March.

₹ croreMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue from operations7.97.39.910.37.510.311.013.913.912.2
7.06.9–9.7–9.810.113.113.011.3
Materials and goods bought5.85.68.07.95.87.87.910.710.58.8
Employee costs0.40.5–0.8–0.91.11.21.21.3
Other expenses0.70.8–1.0–1.11.11.11.31.2
Operating profit before depreciation0.90.5–0.7–0.61.00.80.90.9
Operating margin11.9%6.4%–6.4%–5.5%8.7%5.6%6.7%7.4%
Materials, % of revenue74.0%75.9%–76.6%–75.5%71.8%77.4%75.7%72.3%
Employee costs, % of revenue5.6%7.2%–7.3%–8.6%9.6%8.9%8.6%10.7%
Other expenses, % of revenue8.5%10.5%–9.6%–10.4%9.9%8.1%9.1%9.7%
Depreciation and amortisation0.50.5–0.4–0.30.30.30.30.5
Operating profit after depreciation0.50.0–0.3–0.30.60.50.70.4
Other income0.20.40.40.00.10.10.00.10.00.0
Finance costs0.30.20.10.10.00.00.00.00.10.1
One-off items–––0.0––––––
Profit before tax0.40.20.20.20.20.30.70.60.60.3
0.10.10.10.10.10.10.10.20.20.1
Net profit0.20.10.10.10.20.20.60.50.40.2
Net margin2.7%1.3%1.3%1.1%2.1%2.1%5.2%3.3%3.2%2.0%
Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the years to Mar 2019 and Mar 2021: the statement does not state its depreciation, which operating profit is worked out from, so operating profit is not given.

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
6.36.36.56.77.27.78.18.3
Share capital3.33.33.33.33.33.33.33.3
Reserves3.03.03.23.43.94.44.85.0
Borrowings1.11.11.01.01.00.50.90.8
3.21.71.92.01.52.61.31.5
Liabilities due after a year1.11.11.01.01.00.50.90.8
Total assets10.59.19.39.79.710.910.310.5
2.27.31.71.52.01.93.03.2
8.31.87.78.27.78.97.37.3
Net debt0.00.80.40.60.80.10.4−0.3
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Standalone, ₹ crore, years to March.

₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
0.53−0.060.461.210.741.51
0.620.150.571.480.921.49
0.11−0.35−0.400.56−0.040.69
Receivables−0.78−0.240.010.751.541.02
Inventories0.68−0.300.05−1.17−0.43−0.02
Payables0.230.18−0.871.24−1.140.07
Other working capital−0.020.010.41−0.26−0.01−0.38
Tax paid0.000.00−0.11−0.26−0.17−0.08
Interest paid0.000.000.000.000.000.11
Capital spending0.170.120.660.130.001.72
Free cash flow0.36−0.18−0.201.080.74−0.21
−0.10−0.10−0.66−0.52−0.97−0.61
−0.11−0.040.01−0.460.27−0.26
Dividends paid0.02–0.020.020.020.02
Shares issued0.000.000.000.000.000.00
Net change in cash0.32−0.20−0.200.230.040.64
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020. Dividends paid is left blank for the year to Mar 2022: the cash-flow statement states no dividends paid, while the company's own dividend record shows one paid in the period, so the line is not given. Interest paid is left blank for the year to Mar 2023: the line is filed below nought and is smaller than the rounding of its section's total, so the statement does not show which way it moved cash.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Earnings per share₹0.89₹0.29–₹0.34₹0.37₹0.65₹1.74₹1.38₹1.33₹0.74
Diluted earnings per share₹0.89₹0.29–₹0.34₹0.37₹0.65₹1.74₹1.38₹1.33₹0.74
Dividend per share₹0.05₹0.05₹0.05₹0.05₹0.05₹0.05₹0.05₹0.05₹0.05₹0.05
Book value per share––₹18.95₹19.23₹19.56₹20.21₹21.89₹23.22₹24.50₹25.20
Dividend payout–17.2%13.1%14.7%10.4%7.7%2.9%3.6%3.8%6.7%
Shareholder yield––––0.1%––––0.0%
Market cap at the year end (₹ crore)–9.910.010.911.311.4–––41.7
Earnings per share is left blank for the year to Mar 2019: the earnings per share is stated as 0 while the period's profit or loss comes to at least half a paisa a share, so the 0 stands in for a figure the filing does not give. Shareholder yield is left blank for the year to Mar 2022: the cash-flow statement states no dividends paid, while the company's own dividend record shows one paid in the period, so the line is not given.

Ratios

Standalone, years to March.

RatioMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue growth–−7.3%34.6%4.9%−27.4%37.4%6.9%25.9%0.4%−12.4%
Operating profit growth–−49.9%––––70.3%−18.5%18.8%−3.5%
Net profit growth–−55.1%31.6%−11.0%40.8%35.8%166.4%−20.8%−3.1%−44.2%
Earnings per share growth–−67.4%––8.8%75.7%167.7%−20.7%−3.6%−44.4%
––2.0%1.8%2.5%3.3%8.2%6.1%5.6%3.0%
–––−0.2 pts0.7 pts0.8 pts5.0 pts−2.2 pts−0.5 pts−2.6 pts
From the net margin–––−0.3 pts1.7 pts0.0 pts4.9 pts−3.1 pts−0.2 pts−2.0 pts
From asset turnover–––0.2 pts−0.8 pts0.8 pts0.4 pts1.0 pts−0.2 pts−0.4 pts
From borrowing–––−0.1 pts−0.2 pts0.0 pts−0.3 pts−0.1 pts−0.2 pts−0.2 pts
Return on capital employed–––3.4%–3.6%7.8%6.5%7.4%4.7%
Cash conversion––––334.9%−27.3%80.0%266.3%167.8%616.5%
Interest cover1.70.1–3.6–7.03,217.025.58.04.0
Debt to equity––0.180.170.160.150.140.070.110.09
Receivable days––187030523121615211196
Inventory days––82624245427187105
Payable days–––71––––4252
Cash conversion cycle, days–––−8––––156149
Working capital days––148−5253204200154144142
Asset turnover––0.941.050.811.081.141.351.321.17
Assets per rupee of net worth––1.681.561.441.451.401.381.351.27
Sales per rupee of plant––4.47–4.546.976.058.448.304.17
Capital spending to depreciation–––––0.412.080.530.003.65
No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2026.

Return on assets, latest year
2.4%
Cash from operations against operating profit
168.6%
Measure10 years5 years3 years
Revenue growth, yearly rate–10.2%3.5%
Profit growth, yearly rate–9.2%−24.6%
Return on equity, average–5.2%4.9%
Return on capital employed, average–6.0%6.2%
Operating margin, average–6.8%6.6%
Net margin, average2.4%3.1%2.8%
Asset turnover, average–1.211.28
Cash conversion cycle, days, average––153
Interest cover, average–652.312.5
Debt to equity, average–0.110.09

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations3.863.461.51
Cash from investing−2.87−2.10−0.61
Cash from financing−0.48−0.45−0.26
Capital spending2.631.851.72
Dividends paid–0.050.02
Shares issued for cash0.000.000.00
Borrowings raised–0.370.00
Borrowings repaid0.590.590.14

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Altman Z-scorePublished threshold 1.81–––4.08––––––
Receivables growth less revenue growthOur threshold 0 percentage points–––−104.91–−33.53−6.62−37.46−27.02−11.61
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–––−24.22−23.429.90−6.3791.4022.5616.98
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–––−2.861.641.96−2.223.99−4.013.12
Effective tax ratePublished threshold 17.16 per cent39.6146.9639.8438.3633.2524.5513.0024.9127.9125.67
Tax charged less tax paid, % of profitOur threshold 10 percentage points–––––24.55−3.26−18.75−0.542.91
A threshold marked as ours has no published figure; it is the line we read the check against.

Business segments

In the year to Mar 2026 the company reports one business segment, Medical, which carries all its revenue.

Who owns KMS Medisurgi, filing by filing

Per cent of the company's shares. Every filing on record, from Mar 2018; the latest is the filing of 30 Sep 2026.

30 Sep 2026 filing

  • Promoters74.42%
  • Individuals and others25.58%

Shareholding pattern, per cent, from Dec 2022

  • Promoters
  • Individuals and others
74.42%25.58%74.42%74.42%74.42%74.42%74.42%74.42%74.42%74.42%74.42%74.42%74.42%74.42%74.42%25.58%25.58%25.58%25.58%25.58%25.58%25.58%25.58%25.58%25.58%25.58%25.58%25.58%Dec 22Jun 23Mar 24Sep 24Jun 25Mar 26Sep 26
Per centMar 2018Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020Dec 2021Mar 2022Jun 2022Dec 2022Mar 2023Jun 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Jun 2025Dec 2025Mar 2026Jun 2026Sep 202630 Sep
72.73%74.42%74.42%74.42%74.42%74.42%74.42%74.42%74.42%74.42%74.42%74.42%74.42%74.42%74.42%74.42%74.42%74.42%74.42%74.42%74.42%74.42%
Indian promoters72.73%74.42%74.42%74.42%74.42%74.42%74.42%74.42%74.42%74.42%55.21%55.21%55.21%74.42%74.42%74.42%74.42%74.42%74.42%74.42%74.42%74.42%
Foreign promoters––––––––––19.21%19.21%19.21%–––––––––
27.27%25.58%25.58%25.58%25.58%25.58%25.58%25.58%25.58%25.58%25.58%25.58%25.58%25.58%25.58%25.58%25.58%25.58%25.58%25.58%25.58%25.58%
Shares in issue33,00,00033,00,00033,00,00033,00,00033,00,00033,00,00033,00,00033,00,00033,00,00033,00,00033,00,00033,00,00033,00,00033,00,00033,00,00033,00,00033,00,00033,00,00033,00,00033,00,00033,00,00033,00,000
Shares locked in24,00,000–7,06,000–––––––––––––––––––
Promoters' shares locked in24,00,000–7,06,000–––––––––––––––––––
Filings before Dec 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. A dash is a line the filing did not state.

Number of KMS Medisurgi shareholders

Shareholders on the company's register in each filing.

Shareholders, filing by filing

73Mar 1854Dec 1954Mar 2052Jun 2051Sep 2051Dec 2054Dec 2153Mar 2255Jun 2256Dec 2257Mar 2357Jun 2359Dec 2359Mar 2459Jun 2459Sep 2459Dec 2467Jun 2564Dec 2564Mar 2663Jun 2663Sep 26
ShareholdersMar 2018Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020Dec 2021Mar 2022Jun 2022Dec 2022Mar 2023Jun 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Jun 2025Dec 2025Mar 2026Jun 2026Sep 202630 Sep
All shareholders73545452515154535556575759595959596764646363
9999999999999999999999
Indian promoters9999999999888999999999
Foreign promoters––––––––––111–––––––––
64454543424245444647484850505050505855555454
Filings before Dec 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. A dash is a line the filing did not state.

KMS Medisurgi promoters

Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing of 30 Sep 2026; the largest is MONI DIAMONDS LIMITED, 19.21%.

Holder
MONI DIAMONDS LIMITEDIndian companies, trusts and others19.21%6,34,000
REKHA DEVANG KANAKIAIndividuals and Hindu undivided families13.39%4,42,000
SUSHILA PRATAPRAI KANAKIAIndividuals and Hindu undivided families13.33%4,40,000
ANAND PRATAPRAI KANAKIAIndividuals and Hindu undivided families10.22%3,37,400
GAURANG PRATAPRAI KANAKIAIndividuals and Hindu undivided families9.94%3,28,180
AMRITA GAURANG KANAKIAIndividuals and Hindu undivided families5.09%1,68,000
SIDDHARTH GAURANG KANAKIAIndividuals and Hindu undivided families1.52%50,000
KAUSHALI GAURANG KANAKIAIndividuals and Hindu undivided families0.85%28,210
MONALI KANAKIAIndividuals and Hindu undivided families0.85%28,210
No promoter shares are reported as pledged.

Largest public holders of KMS Medisurgi, filing by filing

Per cent, on the same shares as the split above.

HolderMar 2018Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020Dec 2021Mar 2022Jun 2022Dec 2022Mar 2023Jun 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Jun 2025Dec 2025Mar 2026Jun 2026Sep 202630 Sep
YAGNESH MANAHARLAL JOSHIResident individuals, over ₹2 lakh at face value1.21%1.58%1.58%1.58%1.58%1.58%1.58%1.58%1.58%5.82%5.82%5.82%5.82%5.82%5.82%5.82%5.82%5.82%5.82%5.82%5.82%5.82%
LALBAHADUR RUDRAMANI MISHRAResident individuals, over ₹2 lakh at face value––––––2.30%2.30%2.30%2.30%2.30%2.30%2.30%2.30%2.30%2.30%2.30%2.30%2.30%2.30%2.30%2.30%
VIMLA M SHAHResident individuals, over ₹2 lakh at face value––––––––––––––––––1.67%1.67%1.67%1.67%
ASHOK BABUBHAI LADEResident individuals, over ₹2 lakh at face value1.94%2.06%2.06%2.30%2.30%2.30%2.06%2.06%1.94%1.58%1.45%1.33%1.27%1.27%1.27%1.27%1.27%1.27%1.24%1.24%1.27%1.27%
KINDLE BROKING PRIVATE LIMITEDCompanies––––––1.21%1.21%1.21%1.21%1.21%1.21%1.21%1.21%1.21%1.21%1.21%1.21%1.21%1.21%1.21%1.21%
SHRENIK PRAFULCHANDRA SANGHVIResident individuals, over ₹2 lakh at face value–1.09%1.09%1.09%1.09%1.09%1.09%1.09%1.09%1.09%1.09%1.09%1.09%1.09%1.09%1.09%1.09%1.09%1.09%1.09%1.09%1.09%
MEGHNA INFRACON INFRASTRUCTURE LIMITEDCompanies––––––––––––––––2.30%–––––
NAYSAA SECURITIES LIMITEDCompanies2.42%3.03%3.15%3.15%3.15%3.15%2.30%2.30%2.30%2.30%2.30%2.30%2.30%2.30%2.30%2.30%––––––
MOTIVE BROKING & ADVISORY PRIVATE LIMITEDOther non-institutions4.24%4.24%4.24%4.24%4.24%4.24%4.24%4.24%4.24%–––––––––––––
NAWAL AGRAWALResident individuals, over ₹2 lakh at face value–2.06%2.06%2.06%2.06%2.06%––––––––––––––––
DODIA GITA HITESHResident individuals, over ₹2 lakh at face value1.82%1.33%––––––––––––––––––––
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. A dash is a filing that did not name the holder, which includes holding under one per cent.

KMS Medisurgi dividend calendar

Each payment in the month it went ex, as declared, ₹ a share at the time. Years running counted to the year to Mar 2026.

  • Paid 10 years running, from the year to Mar 2017
Dividends by the month each went ex
YearJanFebMarAprMayJunJulAugSepOctNovDecIn the year
2026₹0.05₹0.05
2025₹0.05₹0.05
2024₹0.05₹0.05
2023₹0.05₹0.05
2022₹0.05₹0.05
2021₹0.05₹0.05
2020₹0.05₹0.05
2019₹0.05₹0.05

Interim or final dividendSpecial dividendNone that month

Dividends by year

The share of each year's profit paid out, for the year it was paid for.

Share of profit paid out, %, where the year's results are on record

Mar 1717Mar 1813Mar 1915Mar 2010Mar 217.7Mar 222.9Mar 233.6Mar 243.8Mar 256.7Mar 26
Highest 17% of profit, year to Mar 2018.

KMS Medisurgi dividend history

Every payment with its ex-date and record date, year by year.

2026

  • Sep23Wed

    ₹0.05Final

    Ex-date and record date 23 Sep 2026

    0.04%of the price

2025

  • Sep23Tue

    ₹0.05Final

    Ex-date and record date 23 Sep 2025

    0.04%of the price

2024

  • Sep23Mon

    ₹0.05Final

    Ex-date and record date 23 Sep 2024

    0.04%of the price

2023

  • Sep22Fri

    ₹0.05Final

    Ex-date 22 Sep 2023 · record date 23 Sep 2023

    0.05%of the price

2022

  • Sep22Thu

    ₹0.05Final

    Ex-date 22 Sep 2022 · books closed to 30 Sep 2022

    0.15%of the price

2021

  • Sep21Tue

    ₹0.05Final

    Ex-date 21 Sep 2021 · books closed to 30 Sep 2021

    0.15%of the price

2020

  • Sep22Tue

    ₹0.05Final

    Ex-date 22 Sep 2020 · books closed to 30 Sep 2020

    0.14%of the price

2019

  • Sep19Thu

    ₹0.05Final

    Ex-date 19 Sep 2019 · books closed to 30 Sep 2019

    0.17%of the price

2018

  • Sep19Wed

    ₹0.05Final

    Ex-date 19 Sep 2018 · books closed to 29 Sep 2018

    0.16%of the price

2017

  • Sep21Thu

    ₹0.05Final

    Ex-date 21 Sep 2017 · books closed to 30 Sep 2017

    0.16%of the price

Grouped by the calendar year each went ex, so a year's total here can differ from the year it was paid for above. Of the price is the dividend as a share of the close on the session before its ex-date. A book closure is the run of days the company's register is frozen to settle who is paid; a record date is the one-day form of it.

KMS Medisurgi share price by year

Each calendar year to 2025.

YearClose at year endChangeHighest closeLowest close
2025126.50+1.2%126.90120.50
2024125.00+2.5%125.00125.00
2023121.91+196.6%121.9140.00
202241.10+19.7%41.1034.00
202134.35−1.9%36.0033.50
202035.00+16.1%40.4530.15
201930.15+0.2%30.2030.05
201830.10−0.2%33.7030.10
201730.15–32.7530.00
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2025 is from its first session, 27 Jun 2025. 2024 is from its first session, 5 Apr 2024. 2022 is from its first session, 15 Mar 2022. 2020 is from its first session, 24 Jan 2020. 2017 is from its first session, 24 Apr 2017. The close is the year's last trade for 2025 (16 Sep 2025), 2024 (5 Apr 2024), 2023 (20 Nov 2023), 2021 (3 Dec 2021), 2020 (8 Sep 2020), 2019 (2 Dec 2019), 2018 (20 Nov 2018) and 2017 (28 Nov 2017).

Recent sessions

The 10 trading days to 13 May 2026, as traded on BSE.

DateOpenHighLowCloseAverage priceVolume
13 May 2026132.80132.80132.80132.80132.802,000
30 Mar 2026126.50126.50126.50126.50126.501,000
16 Sep 2025126.50126.50126.50126.50126.5027,000
5 Aug 2025126.50126.50126.50126.50126.5021,000
25 Jul 2025126.50126.50126.50126.50126.501,000
24 Jul 2025120.50120.50120.50120.50120.5020,000
23 Jul 2025132.30132.30120.50120.50126.402,000
9 Jul 2025126.00126.00126.00126.00126.002,000
4 Jul 2025126.00126.20125.50125.50125.9115,000
27 Jun 2025125.10127.00125.00126.90126.1076,000
Prices in ₹ per share as traded, not adjusted.

Company details

BSE code
540468
ISIN
INE870V01014
Industry
Healthcare Equipment & Supplies
CIN
L51397MH1999PLC119118
Corporate identity number, the registrar of companies' code for it
Incorporated
1999
Registered office
297/301, May Building,, Ground Floor,, Marine Lines (East),, Princess Street, Mumbai 400002, Maharashtra
Share registrar
KFin Technologies Ltd
Keeps the register of shareholders and handles transfers and dividend payments